UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 62 filers reported holding UNIQURE NV in Q3 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,730,000 | +16.5% | 84,600 | +53.8% | 0.33% | +136.4% |
| Q2 2015 | $1,485,000 | +11.0% | 55,000 | 0.0% | 0.14% | +11.1% |
| Q1 2015 | $1,338,000 | +64.2% | 55,000 | 0.0% | 0.13% | +61.5% |
| Q4 2014 | $815,000 | +60.1% | 55,000 | 0.0% | 0.08% | +47.2% |
| Q3 2014 | $509,000 | -31.9% | 55,000 | 0.0% | 0.05% | -17.2% |
| Q2 2014 | $747,000 | -12.8% | 55,000 | 0.0% | 0.06% | -8.6% |
| Q1 2014 | $857,000 | – | 55,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |